CL2007003660A1 - USE OF A BACTERIA OF GENDER NOCARDIA TO MANUFACTURE A VACCINE TO COMBAT GRAM-NEGATIVE NON-NOCARDIAL BACTERIAL INFECTION IN FISH. - Google Patents

USE OF A BACTERIA OF GENDER NOCARDIA TO MANUFACTURE A VACCINE TO COMBAT GRAM-NEGATIVE NON-NOCARDIAL BACTERIAL INFECTION IN FISH.

Info

Publication number
CL2007003660A1
CL2007003660A1 CL200703660A CL2007003660A CL2007003660A1 CL 2007003660 A1 CL2007003660 A1 CL 2007003660A1 CL 200703660 A CL200703660 A CL 200703660A CL 2007003660 A CL2007003660 A CL 2007003660A CL 2007003660 A1 CL2007003660 A1 CL 2007003660A1
Authority
CL
Chile
Prior art keywords
nocardial
nocardia
gender
vaccine
fish
Prior art date
Application number
CL200703660A
Other languages
Spanish (es)
Inventor
Luc Labrie Laura Grisez
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of CL2007003660A1 publication Critical patent/CL2007003660A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CL200703660A 2006-12-18 2007-12-17 USE OF A BACTERIA OF GENDER NOCARDIA TO MANUFACTURE A VACCINE TO COMBAT GRAM-NEGATIVE NON-NOCARDIAL BACTERIAL INFECTION IN FISH. CL2007003660A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06126409 2006-12-18

Publications (1)

Publication Number Publication Date
CL2007003660A1 true CL2007003660A1 (en) 2008-07-25

Family

ID=37744423

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200703660A CL2007003660A1 (en) 2006-12-18 2007-12-17 USE OF A BACTERIA OF GENDER NOCARDIA TO MANUFACTURE A VACCINE TO COMBAT GRAM-NEGATIVE NON-NOCARDIAL BACTERIAL INFECTION IN FISH.

Country Status (3)

Country Link
CL (1) CL2007003660A1 (en)
TW (1) TW200843789A (en)
WO (1) WO2008074783A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200936759A (en) * 2007-12-21 2009-09-01 Intervet Int Bv Fish vaccine
CN111304131B (en) * 2020-03-17 2021-07-16 中国水产科学研究院黄海水产研究所 Pathogenic mermaid photobacterium mermaid subspecies strain and application thereof
CN112481183A (en) * 2020-12-07 2021-03-12 广东海洋大学深圳研究院 Nocardia seriolae attenuated as well as construction method and application thereof
CN113648407A (en) * 2021-08-20 2021-11-16 广东渔跃生物技术有限公司 Application of nocardia immunopotentiator in fish vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2184531B1 (en) * 1972-05-19 1975-10-17 Anvar

Also Published As

Publication number Publication date
WO2008074783A1 (en) 2008-06-26
TW200843789A (en) 2008-11-16

Similar Documents

Publication Publication Date Title
ES2523968T3 (en) Antibacterial combination therapy for the treatment of infections by Gram-positive bacteria
EP2545068B8 (en) Immunogenic composition or vaccine against gram-negative bacterial, for example neiserial, infection or disease
AR072435A1 (en) NUTRITIONAL COMPOSITION FOR CHILDREN BORN BY CESAREA
BRPI1007885A2 (en) antiseptic bismutholols for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
CL2016001524A1 (en) Antibacterial derivatives of 1h-indazole and 1h-indole.
CL2014000470A1 (en) Compounds derived from 2-oxo-pyridine-3-carboxylic acid; pharmaceutical composition; combination; and its use to treat or improve a bacterial infection.
CR10075A (en) BIFENYL CARBOXAMIDS TO COMBAT MICROORGANISMS.
BR112013011693A2 (en) hydroxamic acid derivatives and their use in the treatment of bacterial infections
ES2571998T3 (en) Compositions and medical uses of ajoene derivatives
CL2014001154A1 (en) Antibiotic derivative compounds of 2-oxo-oxazolidin-3,5-diyl of formula i; pharmaceutical composition; use for the prevention or treatment of a bacterial infection.
CL2013002313A1 (en) Erythromycin-derived macrolide compounds substituted in c-4 "position with methyl amino substituted with antibiotic activity; intermediary compounds; pharmaceutical composition, use in prophylaxis or treatment of bacterial infections resistant to erythromycin.
CL2012003168A1 (en) Pharmaceutical composition comprising an aqueous solution of minocycline and a divalent or trivalent cation in a ratio greater than 2: 1 with respect to the minocycline; Preparation method; kit and use in the treatment of bacterial infections.
WO2014127351A3 (en) Compositions and methods to alter gut microbial fermentation using sulfate-reducing bacteria
CL2008003262A1 (en) Vaccine comprising Lactococcus garviae, Pasteurella piscicida, Vibrio anguillarum and Nocardia Seriouslae; and use of said bacteria to combat nocardia infections in fish.
GT200900319A (en) (OXAZOLIDINON-5-IL-METIL) -2-REPLACED THIOPHEN-CARBOXAMIDS AND ITS USE IN THE FIELD OF THE BLOOD COAGULATION
MX2017009094A (en) Polymyxin derivative and uses thereof.
EP2702142A4 (en) A method for use of biologic agents including live or dormant forms of bacteria and other organisms in treating infections, inflammation and other diseases of distal small intestine and large intestine
CL2007003660A1 (en) USE OF A BACTERIA OF GENDER NOCARDIA TO MANUFACTURE A VACCINE TO COMBAT GRAM-NEGATIVE NON-NOCARDIAL BACTERIAL INFECTION IN FISH.
AR053775A1 (en) NONADEPSIPEPTIDES ACILATED II
BR112012024999A2 (en) combination and use
ECSP088907A (en) VACCINE AGAINST RICKETTSIA SIMILAR ORGANISMS
CL2007003517A1 (en) COMPOUNDS DERIVED FROM REPLACED QUINOLINE; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; PHARMACEUTICAL COMBINATION; AND USE IN THE TREATMENT OF A BACTERIAL INFECTION.
ATE524488T1 (en) LYSOBACTINAMIDE
BRPI1015351A2 (en) resistance to bacterial infection
AU2009309277A8 (en) Efficient expression of truncated human RNASET2 in E. Coli